Stock Fundamentals

Company Information

▼
Company Name
Verona Pharma PLC ADR
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US9250501064
CIK: 0001657312
CUSIP: 925050106
Currency: USD
Full Time Employees: 209
Phone: 44 20 3283 4200
Website: https://www.veronapharma.com
Fiscal Year End: December
IPO Date: Apr 27, 2017
Description:

Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company offers Ohtuvayre, a dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that combines bronchodilator and non-steroidal anti-inflammatory effects for the maintenance treatment of chronic obstructive pulmonary disease, as well as cystic fibrosis and asthma. Verona Pharma plc was formerly known as Isis Resources plc and changed its name to Verona Pharma plc in September 2006. The company was incorporated in 2005 and is based in London, the United Kingdom. As of October 7, 2025, Verona Pharma plc operates as a subsidiary of Merck Sharp & Dohme LLC.

Address:

3 More London Riverside, London, United Kingdom, SE1 2RE

Directors & Officers

▼
Name Title Year Born
Dr. David Scott Zaccardelli Pharm.D. President, CEO & Executive Director 1964
Mr. Mark W. Hahn CPA Chief Financial Officer 1963
Mr. Andrew Fisher General Counsel 1970
Dr. Kathleen A. Rickard M.D. Chief Medical Officer 1958
Ms. Victoria Stewart Senior Director of Investor Relations & Communications NA
Mr. Matthew Casbon VP of Sales, Marketing & Training NA
Ms. Ostra Jewell Senior Vice President of Human Resources NA
Dr. Tara Rheault M.P.H., Ph.D. Chief Development Officer 1976
Mr. Christopher Martin Chief Commercial Officer NA
Ms. Caroline Diaz Chief Regulatory Officer NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
HHG PLC 6.13M Jun 30, 2025 7.09% $0.28 11.19%
Perceptive Advisors LLC 5.51M Jun 30, 2025 6.37% $19.31 -16.09%
Darwin Global Management, Ltd. 4.13M Jun 30, 2025 4.77% $16.26 5.26%
RTW INVESTMENTS, LLC 3.05M Jun 30, 2025 3.53% $4.11 7.13%
Eventide Asset Management, LLC 2.72M Jun 30, 2025 3.14% $4.50 -6.16%
Goldman Sachs Group Inc 2.62M Jun 30, 2025 3.03% $0.03 151.32%
NEA Management Company, LLC 2.26M Jun 30, 2025 2.62% $16.11 -15.82%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 2.14M Jun 30, 2025 2.48% $5.13 -7.70%
Farallon Capital Management, L.L.C. 1.81M Jun 30, 2025 2.09% $0.74 66.82%
T. Rowe Price Associates, Inc. 1.79M Jun 30, 2025 2.07% $0.02 -4.11%
Wellington Management Company LLP 1.63M Jun 30, 2025 1.88% $0.03 -23.54%
Hood River Capital Management LLC 1.56M Jun 30, 2025 1.81% $2.06 1.97%
Caligan Partners LP 1.44M Jun 30, 2025 1.66% $26.13 0.00%
D. E. Shaw & Co LP 1.42M Jun 30, 2025 1.64% $0.09 130.49%
Citadel Advisors Llc 1.40M Jun 30, 2025 1.61% $0.02 306.33%
Vivo Capital, LLC 1.39M Jun 30, 2025 1.61% $13.49 -3.15%
UBS Group AG 1.19M Jun 30, 2025 1.37% $0.02 351.27%
Franklin Resources Inc 1.16M Jun 30, 2025 1.34% $0.03 14.40%
Federated Hermes Inc 1.15M Jun 30, 2025 1.33% $0.20 -9.60%
Holocene Advisors, LP 1.08M Jun 30, 2025 1.24% $0.25 -21.29%

Shares Statistics

▼
Shares Outstanding: 84.98M
Shares Float: 564.82M
% Insiders: 488.70%
% Institutions: 9,222.70%
Short % Float: 2.44%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 HHG PLC 6.13M 7.09% ▲ 11.19% Jun 30, 2025
2 Perceptive Advisors LLC 5.51M 6.37% ▼ 16.09% Jun 30, 2025
3 Darwin Global Management, Ltd. 4.13M 4.77% ▲ 5.26% Jun 30, 2025
4 RTW INVESTMENTS, LLC 3.05M 3.53% ▲ 7.13% Jun 30, 2025
5 Eventide Asset Management, LLC 2.72M 3.14% ▼ 6.16% Jun 30, 2025
6 Goldman Sachs Group Inc 2.62M 3.03% ▲ 151.32% Jun 30, 2025
7 NEA Management Company, LLC 2.26M 2.62% ▼ 15.82% Jun 30, 2025
8 SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 2.14M 2.48% ▼ 7.70% Jun 30, 2025
9 Farallon Capital Management, L.L.C. 1.81M 2.09% ▲ 66.82% Jun 30, 2025
10 T. Rowe Price Associates, Inc. 1.79M 2.07% ▼ 4.11% Jun 30, 2025

Valuation Metrics

▼
Enterprise Value: $8.99B
Trailing P/E: 0.00
Forward P/E: 35.34

Financial Highlights

▼
Market Cap: $9.09B
EBITDA: $-52.74M
PEG Ratio: $0.00
Book Value: $3.24
Earnings/Share: $-1.04
Profit Margin: -36.63%
Operating Margin: 12.90%
ROA (TTM): -6.68%
ROE (TTM): -36.36%
Revenue (TTM): $221.67M
Revenue/Share (TTM): $2.65
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 10.63x 0.60x 0.57x -5.25x -1.02x
2023-12-31 33.33x 0.20x 0.19x -25.67x -0.96x
2022-12-31 12.77x 0.05x 0.11x -120.27x -0.19x
2021-12-31 5.09x 0.04x 0.21x -159.45x -0.13x
2020-12-31 14.26x 0.03x 0.09x -1,551.86x -0.13x
2019-12-31 4.26x 0.01x 0.25x -178.52x -0.02x
2018-12-31 7.01x 0.00x 0.15x -190.26x 0.00x
2017-12-31 10.13x 0.01x 0.11x -301.63x -0.05x
2016-12-31 4.03x 0.00x 0.25x -67.17x 0.00x
2015-12-31 3.07x 0.00x 0.24x N/A 0.00x
2014-12-31 21.47x 0.00x 0.04x N/A 0.00x
2013-12-31 1.74x 0.00x 0.19x N/A 0.00x
2012-12-31 5.86x 0.00x 0.07x N/A 0.00x
2011-12-31 16.78x 0.00x 0.04x N/A 0.00x
2010-12-31 10.06x 0.00x 0.06x N/A 0.00x
2009-12-31 11.19x 0.00x 0.06x N/A 0.00x
2008-12-31 30.04x 0.00x 0.02x N/A 0.00x
2007-12-31 9.51x 0.00x 0.05x N/A 0.00x
2006-12-31 36.61x 0.00x 0.02x N/A 0.00x
2005-12-31 82.58x 0.00x 0.01x N/A 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 01, 2025 Andrew Fisher N/A Sale 9.58K $13.14 $125.93K
Aug 01, 2025 Lisa Deschamps N/A Sale 9.46K $13.14 $124.36K
Aug 01, 2025 David R Ebsworth N/A Sale 1.90K $13.14 $25.02K
Aug 01, 2025 David Zaccardelli N/A Sale 208.91K $13.14 $2.75M
Aug 01, 2025 James Aloysius Brady N/A Sale 824.00 $13.14 $10.83K
Aug 01, 2025 Kathleen A Rickard N/A Sale 58.34K $13.14 $766.54K
Aug 01, 2025 Kenneth Cunningham N/A Sale 10.81K $13.14 $142.02K
Aug 01, 2025 Mahendra Shah N/A Sale 3.61K $13.14 $47.41K
Aug 01, 2025 Mark W Hahn N/A Sale 208.91K $13.14 $2.75M
Aug 01, 2025 Martin Edwards N/A Sale 10.81K $13.14 $142.02K
Aug 01, 2025 Michael Austwick N/A Sale 11.29K $13.14 $148.32K
Aug 01, 2025 Vikas Sinha N/A Sale 4.33K $13.14 $56.87K
Aug 01, 2025 Christina Ackermann N/A Sale 1.81K $13.14 $23.76K
Jun 16, 2025 Andrew Fisher N/A Sale 80.00K $11.53 $922.40K
Jun 11, 2025 David Zaccardelli N/A Sale 400.00K $11.40 $4.56M
Jun 11, 2025 Mark W Hahn N/A Sale 400.00K $11.40 $4.56M
May 29, 2025 David Zaccardelli N/A Sale 208.70K $9.33 $1.95M
May 29, 2025 Mark W Hahn N/A Sale 204.86K $9.33 $1.91M
May 28, 2025 Mark W Hahn N/A Sale 162.70K $9.30 $1.51M
May 28, 2025 David Zaccardelli N/A Sale 157.70K $9.30 $1.47M

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about VRNA.US!